Two Sigma Investments
SPHS

Two Sigma Investments’s Sophiris Bio, Inc. SPHS Stock Holding History

Two Sigma Investments’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-20,320
Closed -$17K – 3698
2018
Q4 		$17K Buy
+20,320
New +$40K ﹤0.01% 2892

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BO
BRR OpCo Columbus, Ohio $814M AUM 9.75% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $690M AUM 22.82% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments's SPHS Position: Q1 2019 in Review

Two Sigma Investments sold out of Sophiris Bio, Inc. (SPHS) in Q1 2019, closing a stake of 20,320 shares — an estimated $17K sold.

Two Sigma Investments first reported a position in SPHS in Q4 2018 and held it in 1 quarter. The position peaked at $17K in Q4 2018. 29 funds tracked by Wall St. Rank hold SPHS as of Q1 2019.

  • Two Sigma Investments reported no remaining Sophiris Bio, Inc. position as of Q1 2019 after selling out during the quarter.
  • Two Sigma Investments sold 20,320 Sophiris Bio, Inc. shares in Q1 2019, an estimated $17K.
  • Two Sigma Investments first reported a position in Sophiris Bio, Inc. in Q4 2018 and held it in 1 quarter.
  • Two Sigma Investments's Sophiris Bio, Inc. position peaked at $17K in Q4 2018.
  • 29 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2019.

Based on Two Sigma Investments's 13F filing for Q1 2019, filed 15 May 2019.